Ascendis Pharma A/S (ASND) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and argenex (NASDAQ:ARGX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking.

Which has more volatility & risk, ASND or ARGX?

Ascendis Pharma A/S has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, argenex has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500.

Is ASND or ARGX more profitable?

argenex has a net margin of 40.20% compared to Ascendis Pharma A/S's net margin of -93.22%. argenex's return on equity of 16.15% beat Ascendis Pharma A/S's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-93.22%	N/A	-33.29%
argenex	40.20%	16.15%	14.33%

Does the MarketBeat Community believe in ASND or ARGX?

argenex received 210 more outperform votes than Ascendis Pharma A/S when rated by MarketBeat users. Likewise, 67.65% of users gave argenex an outperform vote while only 67.30% of users gave Ascendis Pharma A/S an outperform vote.

Company	Underperform	Outperform
Ascendis Pharma A/S	Outperform Votes 457 67.30%	Underperform Votes 222 32.70%
argenex	Outperform Votes 667 67.65%	Underperform Votes 319 32.35%

Does the media refer more to ASND or ARGX?

In the previous week, argenex had 15 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 16 mentions for argenex and 1 mentions for Ascendis Pharma A/S. Ascendis Pharma A/S's average media sentiment score of 0.88 beat argenex's score of 0.58 indicating that Ascendis Pharma A/S is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
argenex	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, ASND or ARGX?

argenex has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than argenex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$393.54M	27.82	-$409.12M	-$6.28	-28.52
argenex	$2.25B	15.53	$833.04M	$16.21	35.33

Do insiders & institutionals have more ownership in ASND or ARGX?

60.3% of argenex shares are held by institutional investors. 40.0% of Ascendis Pharma A/S shares are held by insiders. Comparatively, 2.4% of argenex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Do analysts recommend ASND or ARGX?

Ascendis Pharma A/S currently has a consensus price target of $220.67, indicating a potential upside of 23.22%. argenex has a consensus price target of $729.93, indicating a potential upside of 27.45%. Given argenex's stronger consensus rating and higher possible upside, analysts clearly believe argenex is more favorable than Ascendis Pharma A/S.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00
argenex	0 Sell rating(s)	1 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	3.05

Summary

argenex beats Ascendis Pharma A/S on 16 of the 19 factors compared between the two stocks.